会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明申请
    • HETEROCYCLIC AMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE
    • 作为GLYCOGEN PHOSPHORYLASE的抑制剂的杂环酰胺衍生物
    • US20070043069A1
    • 2007-02-22
    • US11463144
    • 2006-08-08
    • Alan BirchAndrew MorleyAndrew StockerPaul Whittamore
    • Alan BirchAndrew MorleyAndrew StockerPaul Whittamore
    • C07D471/02A61K31/4745
    • C07D495/04
    • Heterocyclic amides of formula (1) wherein: X is N or CH; R4 and R5 together are either —S—C(R6)═C(R7)— or —C(R7)═C(R6)—S—; R6 and R7 are independently selected from, for example hydrogen, halo and C1-4alkyl; A is phenylene or heteroarylene; n is 0, 1 or 2; R1 is selected from for example halo, nitro, cyano, hydroxy, carboxy; R2 is hydrogen, hydroxy or carboxy; R3 is selected from for example hydrogen, hydroxy, aryl, heterocyclyl and C1-4alkyl(optionally substituted by 1 or 2 R8 groups); R8 is selected from for example hydroxy, —COCOOR9, —C(O)N(R9)(R10), —NHC(O)R9, (R9)(R10)N— and —COOR9; R9 and R10 are selected from for example hydrogen, hydroxy, C1-4alkyl (optionally substituted by 1 or 2 R13); R13 is selected from hydroxy, halo, trihalomethyl and C1-4alkoxy; or a pharmaceutically acceptable salt or pro-drug thereof, possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of said heterocyclic amide derivatives and pharmaceutical compositions containing them are described.
    • 式(1)的杂环酰胺其中:X是N或CH; R 4和R 5一起是-SC(R 6)-C(R 7) - 或 -C(R 7)C(R 6)-S-; R 6和R 7独立地选自,例如氢,卤素和C 1-4烷基; A是亚苯基或亚杂芳基; n为0,1或2; R 1选自例如卤素,硝基,氰基,羟基,羧基; R 2是氢,羟基或羧基; R 3选自例如氢,羟基,芳基,杂环基和C 1-4烷基(任选被1或2个R 8取代) 组); R 8选自例如羟基,-COCOOR 9,-C(O)N(R 9)(R 10) ),-NHC(O)R 9,(R 9)(R 10)N - 和-COOR 9 ; R 9和R 10选自例如氢,羟基,C 1-4烷基(任选被1或2个R SUP取代 > 13 ); R 13选自羟基,卤素,三卤代甲基和C 1-4烷氧基; 或其药学上可接受的盐或前药具有糖原磷酸化酶抑制活性,因此在治疗与增加的糖原磷酸化酶活性相关的疾病状态方面具有价值。 描述了制备所述杂环酰胺衍生物和含有它们的药物组合物的方法。
    • 44. 发明授权
    • Edge grinding
    • 边磨
    • US06881130B1
    • 2005-04-19
    • US10018767
    • 2000-04-20
    • Mark Andrew Stocker
    • Mark Andrew Stocker
    • B24B53/00B23H1/04B23H9/00B24B1/00B24B9/00B24B9/06B24B47/22B24B49/04B24B53/065B25J9/16H01L21/304
    • B24B1/00B23H1/04B23H9/00B24B9/065B24B47/22B24B49/04B24B53/065B25J9/1602H01L21/304
    • A method of positioning a grooved grinding wheel relative to a disc-like circular workpiece for edge grinding the workpiece using the groove in the wheel includes the steps of mounting the workpiece for rotation about a first axis, mounting the grinding wheel for rotation about a second parallel axis, effecting relative movement between the workpiece and the wheel to engage the rim of the wheel within the groove and performing a preliminary grind. The position of the wheel is axially adjusted in accordance with the measurements made on the profile of the rim produced by the preliminary grind, and the rim is ground again with a second preliminary grind with the grinding wheel located at the axially shifted position. The steps of grinding and measuring the periphery of the workpiece are repeated until the rim profile possesses the desired accuracy. The final position of the grooved grinding wheel is then utilized for grinding future wafers.
    • 相对于盘状圆形工件定位带槽砂轮的方法,用于使用车轮中的槽边缘研磨工件的步骤包括以下步骤:将工件安装在第一轴线周围,将砂轮安装在第二轴上 平行的轴线,影响工件和车轮之间的相对运动,以使车轮轮缘在槽内啮合并进行预磨。 轮的位置根据由预研磨产生的轮辋轮廓上的测量值进行轴向调节,并且轮辋再次用第二初步磨削研磨,砂轮位于轴向位移位置。 重复磨削和测量工件的周边的步骤,直到轮辋轮廓具有期望的精度。 然后利用开槽砂轮的最终位置研磨未来的晶圆。
    • 50. 发明授权
    • Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
    • 氨基杂环衍生物作为抗血栓形成或抗凝血剂
    • US06730672B2
    • 2004-05-04
    • US09800745
    • 2001-03-08
    • Alan Wellington FaullAndrew StockerColette Marie MayoJohn Preston
    • Alan Wellington FaullAndrew StockerColette Marie MayoJohn Preston
    • C07D40114
    • C07D213/74C07D401/04C07D401/12C07D401/14C07D405/14C07D409/14
    • The invention concerns compounds of formula (I) wherein each of G1, G2 and G3 is CH or N; m is 1 or 2; R1 includes hydrogen, halogeno and (1-4C)alkyl; M1 is a group of the formula: NR2—L1—T1R3 in which R2 and R3 together form a (1-4C)alkylene group, L1 includes (1-4C)alkylene, and T1 is CH or N; A may be a direct link; M2 is a group of the formula: (T2R4)r—L2—T3R5 in which r is 0 or 1, each of T2 and T3 is CH or N, each of R4 and R5 is hydrogen or (1-4C)alkyl, or R4 and R5 together form a (1-4C)alkylene group, and L2 includes (1-4C)alkylene; M3 may be a direct link to X; X includes sulphonyl; and Q includes naphthyl and a heterocyclic moiety; or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them and their use as antithrombotic or anticoagulant agents.
    • 本发明涉及式(I)化合物,其中G 1,G 2和G 3各自为CH或N; m为1或2; R 1包括氢,卤素和(1-4C)烷基; M 1是下式的基团:其中R 2和R 3一起形成(1-4C)亚烷基,其中R 2,R 2,R 3,R 3, ,L 1包括(1-4C)亚烷基,T 1是CH或N; A可能是直接链接; M 2是下式的基团:(T 2 R 4)r L 2 -T 3 R 5,其中r是0或1,每个T 2和T R 3和R 5分别是氢或(1-4C)烷基,或者R 4和R 5一起形成(1-4C)亚烷基, 和L 2包括(1-4C)亚烷基; M 3可以直接连接到X; X包括磺酰基; 且Q包括萘基和杂环部分; 或其药学上可接受的盐; 其制备方法,含有它们的药物组合物及其作为抗血栓形成或抗凝血剂的用途。